Rochester Clinical Research is currently enrolling adults in a smoking cessation research study evaluating an investigational medication for people who want to quit smoking. The study will look at whether the investigational medication may help participants quit smoking and remain smoke-free.
This study is evaluating an oral investigational medication for adults who want to quit smoking. The study lasts approximately 35 weeks and includes a combination of clinic and remote visits..
Compensation available.
You may be eligible if you:
Other inclusion/exclusion criteria will apply.
Taking part in research is voluntary — and confidential. You will be compensated for your time and travel.
Adults 18 years of age and older with elevated inflammation levels and heart disease or certain health conditions that increase […]
An upcoming clinical research study is evaluating an investigational treatment designed to help prevent the flu in adults who may […]
An upcoming clinical research study is evaluating an investigational vaccine designed to help prevent illness caused by norovirus in adults […]
An upcoming clinical research study is evaluating an investigational long-acting approach designed to help prevent influenza. Join our interest list […]
Adults 65 and older may qualify for a clinical research study evaluating an investigational seasonal flu vaccine.
This clinical trial will help us learn if receiving another dose of the RSV vaccine is safe and can help […]
